The things most people don't know that will help you stand out, win millions, close the deal and succeed. Have you ever wondered why you didn't get the deal, project, promotion, etc.? The decision-makers loved the idea. They loved the team. They loved everything you presented, but they wanted to think about it a little longer. In this enlightening session with world-renowned Communications & Leadership Expert John Bates, you will learn the secrets behind pitches that succeed. You will leave…

Do you think you know the ins-and-outs of federal support for biotech innovators and startups? It is a vast area and goes far beyond SBIR grants and includes diverse support and funding mechanisms through a variety of federal agencies. Join us for an in-person session with representatives from the National Cancer Institute (NCI), National Center for Advancing Translational Sciences (NCATS), as well as the Biomedical Advanced Research and Development Authority (BARDA) and the Federal Drug Administration Office of Science and…

A chance to pitch to an investor or potential partner is a golden opportunity for a biotech startup. It’s also a pressure-packed moment where every minute counts. No matter how great your product or company may be or how valuable your solution may prove to be for patients, you and your team need to convey that impact and tell your story in a way that connects with your audience. It is vital to make the most of the opportunity, going…

Join us for Harnessing the Potential of Antibody Drug Conjugates (ADCs) in Oncology, on October 25 at Johnson & Johnson Innovation - JLABS @ Washington, DC. We’ll host industry thought leaders  as they dig deeper on how ADCs have become a promising cancer treatment and key component in the next generation of oncology therapeutics. Dubbed ‘the next pillar of cancer therapeutics’, ADC technology delivers highly potent treatment agents to specific tumor cells connected to malignancy. From 2019 – 2022, 8…